Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Qinglei Gao

Clinical trials sponsored by Qinglei Gao, explained in plain language.

Not yet recruiting 1

New drug combo aims to shrink Hard-to-Operate ovarian tumors

Disease control Not yet recruiting

This study tests two drug combinations (fluzoparib plus famitinib or fluzoparib plus SHR-1701) given before surgery to shrink advanced ovarian cancer in 104 women whose tumors cannot be fully removed right away. The goal is to see how well these treatments work and how safe they …

Phase 2 • Sponsor: Qinglei Gao • Aim: Disease control

Last updated Jun 27, 2026 08:12 UTC